ArmInfo.Following negotiations with the Swiss pharmaceutical company Hoffmann-La Roche, it was managed to agree on lowering the prices of a number of drugs for the treatment of cancer. The press service of the Ministry of Healthcare of Armenia reports.
According to the source, the Hoffmann-La Roche company has developed the program "Assistance to the sick", the purpose of which is to provide assistance to patients with cancer of the breast, cervix, ovary, kidney, brain. So, if the drug "Herceptin" 440 mg cost 590 thousand drams, now its cost is reduced to 530 thousand drams. At the same time, instead of the market price for the Avastin drug 100 mg at 152 thousand drams, a new price of 105 thousand drams will be applied, and the Avastin drug 400 mg instead of the previous 598.5 thousand drams will be sold for 410 thousand drams. The Armenian Ministry of Healthcare informs that negotiations with Hoffmann-La Roche are continuing on the subject of price cuts for other medicines.
To note, Hoffmann-La Roche is one of the leading and rapidly developing medical companies in the world with headquarters in Basel, Switzerland. The company, commonly known as Roche, was founded in 1896. Today, Roche is one of the leaders in the international healthcare market and operates in more than a hundred countries. The company employs over 60,000 employees. Each year, over $ 2 billion is invested in research and development. All this has the goal of caring for human health. Roche's areas of focus cover the entire spectrum of healthcare: prevention, diagnosis, and therapy. Hoffmann-La Roche creates new, individualized approaches to treating everyone.